Top

Published in:

01-03-2021 | COVID-19 Vaccination | News item

COVID-19 vaccine-related lymphadenopathy may affect breast screening

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Following reports of lymphadenopathy after vaccination with the Moderna COVID-19 vaccine [mRNA-1273] and the Pfizer/BioNTech COVID-19 vaccine [tozinameran], advice has been given that patients who require breast screening should undergo screening prior to COVID-19 vaccination or 4−6 weeks after vaccination, report authors of a Drug Safety Research Unit pharmacovigilance evidence review. …

Lane S, et al. Pharmacovigilance evidence review: the effect of covid-19 vaccines on breast screening. Internet Document : 26 Feb 2021. Available from: URL: https://www.dsru.org/pharmacovigilance-evidence-review-the-effect-of-covid-19-vaccines-on-breast-screening/

Title: COVID-19 vaccine-related lymphadenopathy may affect breast screening
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keywords: COVID-19 Vaccination
Vaccination
Lymphadenopathy
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-92249-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

COVID-19 vaccine-related lymphadenopathy may affect breast screening

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Oxaliplatin

Hydroxychloroquine

Nonacog-alfa

Multiple drugs

Minocycline

Baclofen